[KongchangAI]
Unverified70% confidenceTradeoffTime unknown

同为NAD+前体,NR(烟酰胺核糖)在部分研究中口服吸收路径更明确且已有更多人体数据,预算有限或看重证据强度者可将NR作为NMN的替代方案对比考虑

1
Sources
70%
Confidence
Medium-term (~90 days)
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/200059
API
curl https://kongchang.com/api/v1/knowledge/claims/200059
MCP
get_claim(id=200059)